Ratings EQS Group AG

Equities

EQS

DE0005494165

Market Closed - Xetra 11:36:03 2024-04-10 am EDT 5-day change 1st Jan Change
39.8 EUR -0.75% Intraday chart for EQS Group AG 0.00% -0.75%

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Analyst opinion has improved significantly over the past four months.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

  • The company is in debt and has limited leeway for investment
  • Based on current prices, the company has particularly high valuation levels.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • Over the past twelve months, analysts' opinions have been revised negatively.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Software

1st Jan change Capi. Investor Rating ESG Refinitiv
-0.75% 425M -
+8.05% 3,020B
C+
+5.58% 82.93B
B
+3.69% 76.85B
B+
-14.62% 53.04B
B+
+31.16% 50.15B
D+
-24.56% 46.55B
B-
+17.75% 41.41B
D+
+55.21% 35.63B
D+
-10.24% 24.64B
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality